News Sentiment

AGN sentiment intelligence

Argenica Therapeutics Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 9 relevant articles
Exchange ASX Australia
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.11 Week of 19 Jun 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

89/100 classification confidence.

Company focus 9

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-15.4% over one week, -12.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Why Argenica Therapeutics (ASX:AGN) Shares Are Back in Focus Today?

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 89/100 classification
One-week reaction -15.4% Price reacting lower
Trend fit Trend inactive -12.0% over four weeks
Fair value -79.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 8
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 9
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Kalkine 2
simplywall.st 2
Market source 1
Stockhead 1
Stocks Down Under 1
The Australian 1
TradingView 1

Event Lens

What the news is about

Classified themes
Market update 8
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-9 of 9